Please login to the form below

Not currently logged in

Galen completes acquisition of healthcare company POA Pharma

Takeover expands Galen's global reach and product portfolio

Galen POA Pharma

Galen and POA Pharma combine teams to expand global reach

Global pharmaceutical sales and marketing company Galen has completed a multi-million pound acquisition of healthcare company POA Pharma. 

The takeover of POA Pharma expands Galen’s global reach and product portfolio into new therapy areas, including rare metabolic disease.

POA Pharma is headquartered in Sweden and has further facilities in the Nordic region and North America.

It currently represents 16 producers from ten countries, with a strong product portfolio and extensive worldwide network.

Galen is headquartered in Craigavon, Northern Ireland, and has products in therapy areas including gastroenterology, urology, female health, pain management and mental health.

It first signed a distribution agreement with POA Pharma in April 2016, which allowed Galen to market and sell POA’s metabolic product portfolio in the UK and Ireland.

Simon Lawrence has been appointed as commercial director, Nordics as part of the takeover, after a 33-year career at Galen working across a number of senior management positions.

He will oversee operations in the region and growth the team in line with the global company strategy.

“Galen’s long-heritage and expertise in delivering valued medicines to the people that need them most, coupled with POA Pharma’s important portfolio, means we now have the opportunity to improve the lives of more people affected by a variety of diseases on a truly global scale,” said Lawrence.

“Particularly for the underserved, rare, phenylketonuria (PKU) population, who have limited treatment options available to them, today’s completion is a welcome step towards better access to life-saving nutritional therapies across Galen’s extensive distribution network and beyond,” he added.

Article by
Lucy Parsons

8th January 2020

From: Marketing



COVID-19 Updates and Daily News

Featured jobs


Add my company

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...
Serious about sustainability?
Get to know our new Sustainability Officer here at Cuttsy+Cuttsy...
How scientific storytelling can help Pharma cut through the noise
Rather than being afraid of storytelling, pharmaceutical firms should be embracing it. Because what scientific storytelling allows us to do is to communicate quickly and efficiently. It provides a shortcut...